Clinical trial

Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer

NCT02562118

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2015-10-02

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2015-10-02Date precision: day

Registry last updated2025-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Lenvatinib + LetrozoleDRUG

Sponsors & collaborators

National University Hospital, Singaporelead sponsor

Eisai Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02562118 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.